DAY 1:	Tuesday, July 1, 2008
7:30am	BREAKFAST
8:00 am	Welcome and Opening remarks John Niederhuber, M.D., National Cancer Institute
8:30 am	Session 1: Organization of the NCI Clinical Trials System and Operation of Phase 3 Clinical Trials SESSION 1A: ORGANIZATION OF THE NCI CLINICAL TRIALS SYSTEM Moderator: David Parkinson, M.D., Nodality, Inc.
8:30 am	Jeffrey S. Abrams, M.D., National Cancer Institute       “NCI’s Clinical Trials Program”
9:00 am	Jan C. Buckner, M.D., Mayo Clinic      “Mayo Clinic and North Central Cancer Treatment Group: An Academic-Community Partnership”
9:30 am	Walter J. Curran, Jr., M.D., Winship Cancer Institute, Emory University      “Organization of the Radiation Therapy Oncology Group”
10:00 am	David M. Dilts, Ph.D., M.B.A., Vanderbilt University      “Activating & Opening Oncology Clinical Trials: Process & Timing Analysis”
10:30 am	Richard L. Schilsky, M.D., University of Chicago, Cancer and Leukemia Group B      “Rising to the Challenge of Rapid Protocol Activation”
11:00 am	BREAK
11:15 am	SESSION 1B: OPERATION OF PHASE 3 CLINICAL TRIALS Moderator: Richard L. Schilsky, M.D., University of Chicago
11:15 am	Robert M. Califf, M.D., Duke University      “Organization of Multi-center Trials: Are Oncopolitics Different than Other Clinical Research Politics”
11:45 am	Renzo Canetta, M.D., Bristol-Myers Squibb      “Industry Sponsored Multi-center Trials”
12:15 am	Alan Keller, M.D., F.A.C.P., Cancer Care Associates      “Multi-site Clinical Trials in the Community: Models and Methods: What Works, What Doesn’t, and Why”
12:45 pm	LUNCH
1:30 pm	Session 2: Patient Recruitment and Physician Participation SESSION 2A: PANEL ON ACADEMIC CHALLENGES Moderator:  John Mendelsohn, M.D., MD Anderson Cancer Center
1:30 pm	Academic Panel:  Laurence H. Baker, D.O., Southwest Oncology Group and The University of Michigan      “Southwest Oncology Group View of Barriers to Cooperative Group Accrual”
1:40 pm	Gordon R. Bernard, M.D., Vanderbilt University      “Cancer Clinical Research: The Institutional Perspective”
1:50 pm	Michael A. Caligiuri, M.D., The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
2:00 pm	Allen S. Lichter, M.D., American Society of Clinical Oncology      “The Pitfalls of Career Advancement for the Clinical Trialists: a Decanal Perspective”
2:10 pm	PANEL DISCUSSION
3:00 pm	BREAK
3:15 pm	SESSION 2B: OTHER PERSPECTIVES Moderator: Hal Moses, Vanderbilt University
3:15 pm	Stephen S. Grubbs, M.D., Delaware Christiana Care CCOP      “CCOP Clinical Trials Contributions and Challenges”
3:45 pm	John E. Feldmann, M.D., F.A.C.P., Moses Cone Regional Cancer Center      “Community Cancer Centers - The Crisis in Clinical Trials”
4:15 pm	Richard Kaplan, M.D., National Cancer Research Network, United Kingdom      “Publicly-funded Cooperative Groups Working With Industry”
4:45 pm	Deborah E. Collyar, Patient Advocates in Research      “Connecting Clinical Trials to People”
5:15 pm	Adjourn Day 1
Day 2:	Wednesday, July 2, 2008
7:30 am	BREAKFAST
8:00 am	Welcome and Opening remarks   John Mendelsohn, M.D., MD Anderson Cancer Center
8:15 am	Session 3:  Data collection standards to establish safety and efficacy Moderator: Renzo Canetta, M.D., Bristol-Myers Squibb
8:15 am	James H. Doroshow, M.D., F.A.C.P., National Institutes of Health      “NIH Perspective”
8:35 am	Gwendolyn Fyfe, M.D., Genentech      “A Perspective on How to Quickly Define Data Standards”
8:55 am	Robert L. Comis, M.D., Coalition of National Cancer Cooperative Groups      “The Role of Cooperative Groups in Establishing Safety and Efficacy”
9:15 am	PANEL DISCUSSION: James Doroshow, Gwendolyn Fyfe, Robert Comis, and Richard Pazdur, M.D., F.A.C.P., FDA
10:00 am	BREAK
10:15 am	Session 4:  Costs/Payments Moderator: Robert L. Comis, M.D., Coalition of National Cancer Cooperative Groups
10:15 am	Al B. Benson, III, M.D., F.A.C.P., Robert H. Lurie Comprehensive Cancer Center      “Cooperative Groups and Cost Analysis”
10:45 am	Marcy Waldinger, M.H.S.A., University of Michigan Comprehensive Cancer Center      “Cost-out”
11:15 am	Maurie Markman, M.D., MD Anderson Cancer Center      “Regulatory Compliance:  Impact on Patients and Academic Institutions Conducting Clinical Research”
11:45 am	Leslye K. Fitterman, Ph.D., Centers for Medicare and Medicaid Services      “CMS Clinical Trial Policy”
12:15 pm	Lee N. Newcomer, M.D., M.H.A., United HealthCare      “An Insurer’s View: Paying for Clinical Trials”
12:45 pm	Wrap up John Mendelsohn and Hal Moses
1:00 pm	LUNCH and Adjourn Day 2